Aruna Basu
- Oncology top 5%
- Cancer-related Molecular Pathways 3
- Peptidase Inhibition and Analysis 2
- Molecular Biology top 10%
- Cell death mechanisms and regulation 9
- Mitochondrial Function and Pathology 5
- Glycosylation and Glycoproteins Research 3
- Photosynthetic Processes and Mechanisms 2
- Cancer Research top 10%
- MicroRNA in disease regulation 2
- Cell Biology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 4
Aruna Basu
23 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 690
- Applied Microbiology and Biotechnology 36
- Molecular Biology 1.2k
- Cancer Research 234
- Cell Biology 225
Countries citing papers authored by Aruna Basu
This map shows the geographic impact of Aruna Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aruna Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aruna Basu more than expected).
Fields of papers citing papers by Aruna Basu
This network shows the impact of papers produced by Aruna Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aruna Basu. The network helps show where Aruna Basu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aruna Basu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage. | 2011 | 6 |
| 2 | 2011 | 2 | |
| 3 | 2010 | 9 | |
| 4 | 2009 | 6 | |
| 5 | 2006 | 60 | |
| 6 | 2005 | 176 | |
| 7 | 2003 | 18 | |
| 8 | 2003 | 148 | |
| 9 | 2002 | 53 | |
| 10 | 2002 | 61 | |
| 11 | 2002 | 36 | |
| 12 | 1998 | 55 | |
| 13 | Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. | 1998 | 147 |
| 14 | 1997 | 36 | |
| 15 | Bcl2 is the guardian of microtubule integrity.breakdown → | 1997 | 538 |
| 16 | 1996 | 22 | |
| 17 | Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. | 1995 | 57 |
| 18 | 1992 | 77 | |
| 19 | 1989 | 110 | |
| 20 | 1987 | 145 |
About Aruna Basu
Aruna Basu is a scholar working on Applied Microbiology and Biotechnology, Oncology, Cancer Research, Toxicology and Molecular Biology, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), Mitochondrial Function and Pathology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer-related Molecular Pathways (3 papers), Photosynthetic Processes and Mechanisms (2 papers), MicroRNA in disease regulation (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (690 citations), Applied Microbiology and Biotechnology (36 citations), Molecular Biology (1.2k citations), Cancer Research (234 citations) and Cell Biology (225 citations). Aruna Basu has collaborated with scholars based in United States, Bulgaria and Italy. Frequent co-authors include Carlo M. Croce, Swati Haldar, Subrata Haldar, Suparna Qanungo, Madhusudan Das, Manjusri Das, C M Croce, Saptarsi M. Haldar, Narayan G. Avadhani and Meenhard Herlyn. Their work appears in journals such as Journal of Biological Chemistry, Neoplasia, Frontiers in bioscience, Cancer Research and Biochimica et Biophysica Acta (BBA) - Biomembranes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.